As we enter the Bio Century, AI innovations are becoming pivotal in shaping the future of biology and medicine. In this episode, I am joined by Micha Breakstone, the founder and CEO of Somite.ai, who is at the forefront of integrating AI with stem cell biology. Together, we explore the intersection of AI and health, its history, and its impact on startups and enterprises alike.
Episode Highlights
- AI innovations are transforming biology and medicine, paving the way for revolutionary advances in disease understanding, diagnostics, and treatments.
- Somite.ai, aiming to be the OpenAI for stem cells, is developing a platform to map cell trajectories and guide pluripotent stem cells to become targeted cells for therapeutic use.
- AlphaFold's understanding of protein folding represented a major breakthrough, deepening our scientific understanding and serving as a clear example of AI’s potential impact on biology.
- The evolving landscape is creating tension between traditional asset-focused strategies and AI-driven platform business models, prompting questions about where the true value of these companies lies.
- What's Next, Austin?
- "I would absolutely love to see Austin become a force of nature in moving innovation forward."
What is Austin Next?
Austin's evolution into a global innovation superstar is at the heart of Austin Next. We uncover insights into the region's transformation and what it means for ecosystem building.
Our exploration extends to emerging trends, technologies, and their convergence. Using Austin as our real-world case study and experts from around the world, we aim to understand the true nature and mechanics of innovation.